Neurocrine Biosciences (NBIX) Long-Term Investments (2010 - 2026)
Neurocrine Biosciences (NBIX) recorded Long-Term Investments of $147.3 million in Q2 2026, down 83.1% from $873.8 million a year earlier and down 88.9% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Long-Term Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences reported Long-Term Investments of $1.06 billion, up 43.7% from FY2024.
- Annual Long-Term Investments has increased for three straight years, with a five-year compound annual growth rate of 36.2% (FY2020 to FY2025).
- Across earlier years, Long-Term Investments came in at $739.5 million in FY2024 (+7.6%), $687.5 million in FY2023 (+129.6%), $299.4 million in FY2022 (-46.6%) and $560.7 million in FY2021 (+146.9%).
- The Q2 2026 figure is the lowest quarterly Long-Term Investments since Q2 2019.
- On a year-over-year basis, Long-Term Investments rose in seven of the last eight quarters, with growth averaging 22.7%.
- Peak year-over-year performance for Long-Term Investments in the last five years was growth of 186.3% in Q1 2024, against a decline of 83.1% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.33 billion (Q1 2026), $1.06 billion (Q4 2025) and $998.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 297.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 147.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 147.30 Mn |
| Mar 31, 2026 | 1.33 Bn |
| Dec 31, 2025 | 1.06 Bn |
| Sep 30, 2025 | 998.50 Mn |
| Jun 30, 2025 | 873.80 Mn |
| Mar 31, 2025 | 815.30 Mn |
| Dec 31, 2024 | 739.50 Mn |
| Sep 30, 2024 | 643.90 Mn |
| Jun 30, 2024 | 637.80 Mn |
| Mar 31, 2024 | 700.40 Mn |
| Dec 31, 2023 | 687.50 Mn |
| Sep 30, 2023 | 454.70 Mn |
| Jun 30, 2023 | 342.60 Mn |
| Mar 31, 2023 | 244.60 Mn |
| Dec 31, 2022 | 299.40 Mn |
| Sep 30, 2022 | 362.60 Mn |
| Jun 30, 2022 | 405.20 Mn |
| Mar 31, 2022 | 541.00 Mn |
| Dec 31, 2021 | 560.70 Mn |
| Sep 30, 2021 | 513.70 Mn |
API Access
Neurocrine Biosciences Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();